{"id":"NCT01950260","sponsor":"Mayo Clinic","briefTitle":"Early Levothyroxine Post Radioactive Iodine","officialTitle":"Prevention of Overt Hypothyroidism Following Radioactive Iodine Therapy for Graves' Disease","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2013-09","primaryCompletion":"2017-04","completion":"2017-04","firstPosted":"2013-09-25","resultsPosted":"2019-10-29","lastUpdate":"2019-10-29"},"enrollment":61,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"PREVENTION"},"conditions":["Graves' Disease"],"interventions":[{"type":"DRUG","name":"Levothyroxine","otherNames":["Thyroid hormone"]},{"type":"OTHER","name":"Placebo","otherNames":[]}],"arms":[{"label":"Levothyroxine","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The study will try to answer the question of whether early treatment with levothyroxine at 4 weeks after radioactive iodine for Graves'disease will prevent overt hypothyroidism (low thyroid hormone levels).","primaryOutcome":{"measure":"Number of Participants With Overt Hypothyroidism","timeFrame":"8 weeks","effectByArm":[{"arm":"Levothyroxine","deltaMin":11,"sd":null},{"arm":"Placebo","deltaMin":17,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.23"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":8},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":["https://www.mayo.edu/research/clinical-trials"]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":30},"commonTop":["Palpitations"]}}